Michel Marre
14PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Aug 19, 2025
Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study.Peder Af Geijerstam, John Chalmers, Miriam Pikkemaat
|Dec 11, 2024
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial.Toshiaki Ohkuma, Katie Harris, Mark Woodward
|Mar 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.Leah E Cahill, Rachel A Warren, Allie S Carew
|Dec 05, 2023
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.Sarah Meulebrouck, Victoria Scherrer, Raphaël Boutry
|Dec 23, 2022
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes.Kamel Mohammedi, Michel Marre, Samy Hadjadj
|Aug 27, 2021
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.Johanne Tremblay, Mounsif Haloui, Redha Attaoua
Pageof 3
Frequent Collaborators
7 joint publications
Ronan Roussel
6 joint publications
Kamel Mohammedi
5 joint publications
Samy Hadjadj
5 joint publications
John Chalmers
5 joint publications
Gilberto Velho
4 joint publications
Louis Potier
3 joint publications
Katie Harris
3 joint publications
Sophia Zoungas
3 joint publications
Giuseppe Mancia
3 joint publications
Mark Woodward
